Becton Dickinson Gets FDA 510(k) Clearance for Fingertip Blood-Collection Device
December 07 2023 - 7:43AM
Dow Jones News
By Will Feuer
Becton Dickinson said it has received 510(k) clearance from the
U.S. Federal Drug Administration for its new blood-collection
device that can obtain blood samples from a fingerstick that
produce lab-quality results.
The device, called the BD MiniDraw Capillary Blood Collection
System, is less invasive than traditional blood-collection methods
and means that the blood can be drawn by a trained healthcare
worker, instead of a specialized phlebotomist, BD said.
The company said the device also means that blood could be
collected in more convenient locations, including retail
pharmacies.
BD said the 510(k) clearances include blood collection for a
lipid panel, certain chemistry tests, and hemoglobin and hematocrit
testing, some of the most commonly ordered lab tests. BD also plans
to expand the blood tests that can be enabled by the new device in
the future.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
December 07, 2023 07:28 ET (12:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From May 2024 to Jun 2024
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Jun 2023 to Jun 2024
